GRP78 inhibition enhances ATF4-induced cell death by the deubiquitination and stabilization of CHOP in human osteosarcoma.

New targeted therapies are urgently needed to improve the survival of patients with refractory osteosarcoma (OS). In this study, we show that bortezomib (BTZ), not for OS treatment in the clinic, induces endoplasmic reticulum (ER) stress in U-2 OS cells. Loss of GRP78 sensitizes OS to BTZ with concomitant upregulation ...
of ATF4 and CHOP, which indicates excessive protein synthesis. The relevance of these findings is confirmed in vivo as shown by GRP78 knockdown that delays the growth of U-2 OS xenografts in the presence of BTZ. Here, we demonstrate that MG7, a natural polyyne, can trigger apoptosis. Of note, the apoptotic response to MG7 is dependent on ATF4 but not on the upstream PERK signaling pathway. Interestingly, MG7-induced ATF4 expression does not result in an increase in the levels of CHOP. We demonstrate for the first time that GRP78 physically interacts with the N-terminal domain of CHOP to accelerate its ubiquitination in a p300-dependent manner, which in turn desensitize the tumors to ER stress. Overall, inhibiting GRP78 to strengthen the molecular mechanism of ATF4 via stabilizing CHOP protein may provide a potential vulnerability in OS.
Mesh Terms:
Activating Transcription Factor 4, Animals, Antineoplastic Agents, Apoptosis, Bone Neoplasms, Bortezomib, Cell Death, Cell Line, Tumor, Dose-Response Relationship, Drug, E1A-Associated p300 Protein, Endoplasmic Reticulum Stress, Gene Expression Regulation, Neoplastic, Heat-Shock Proteins, Humans, Male, Mice, Nude, Osteosarcoma, Polyacetylenes, Protein Binding, Protein Interaction Domains and Motifs, Protein Stability, RNA Interference, Signal Transduction, Time Factors, Transcription Factor CHOP, Transfection, Ubiquitination, Xenograft Model Antitumor Assays
Cancer Lett.
Date: Dec. 01, 2016
Download Curated Data For This Publication
211991
Switch View:
  • Interactions 3